Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 781

1.

Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's Disease.

Zarkali A, Lees AJ, Weil RS.

J Parkinsons Dis. 2019 Jun 14. doi: 10.3233/JPD-191635. [Epub ahead of print]

PMID:
31227657
2.

Book Review His last bow.

Lees AJ.

Brain. 2019 Jun 18. pii: awz180. doi: 10.1093/brain/awz180. [Epub ahead of print] No abstract available.

PMID:
31211358
3.

Neuropathological progression of clinical Parkinson disease subtypes.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

Nat Rev Neurol. 2019 Jun;15(6):361. doi: 10.1038/s41582-019-0197-x. No abstract available.

PMID:
31048772
4.

Will the Real James Parkinson Please Stand Up? Another Fake James Parkinson.

Castillo-Torres SA, Soto-Rincon CA, Estrada-Bellmann I, Lees AJ.

Mov Disord Clin Pract. 2019 Jan 16;6(3):269-270. doi: 10.1002/mdc3.12722. eCollection 2019 Mar. No abstract available.

PMID:
30949561
5.

Noticing in Neurology.

Lees AJ.

Pract Neurol. 2019 Apr 4. pii: practneurol-2018-002176. doi: 10.1136/practneurol-2018-002176. [Epub ahead of print]

PMID:
30948556
6.

Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.

Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, Lees AJ, Foltynie T, Houlden H, Church A, Hu MT, Rowe JB, Zetterberg H, Morris HR.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):768-773. doi: 10.1136/jnnp-2018-320151. Epub 2019 Mar 13.

7.

Charcot's capricious scribe.

Lees AJ.

Brain. 2019 Apr 1;142(4):1161-1163. doi: 10.1093/brain/awz047. No abstract available.

PMID:
30820531
8.

The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.

Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, Korlipara P, Morris HR, Bhatia KP, Limousin P, Foltynie T, Lees AJ, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 Feb 1. pii: jnnp-2018-319891. doi: 10.1136/jnnp-2018-319891. [Epub ahead of print] No abstract available.

PMID:
30709896
9.

Apomorphine in the treatment of Parkinson's disease: a review.

Pessoa RR, Moro A, Munhoz RP, Teive HAG, Lees AJ.

Arq Neuropsiquiatr. 2018 Dec;76(12):840-848. doi: 10.1590/0004-282X20180140.

10.

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2019 Jan 14. doi: 10.1001/jamaneurol.2018.4377. [Epub ahead of print]

PMID:
30640364
11.

Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.

Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):555-561. doi: 10.1136/jnnp-2018-319374. Epub 2018 Dec 31.

PMID:
30598430
12.

Sir William Osler's 'Influences' for the Successful Physician, A Reappraisal After 126 Years.

Castillo-Torres SA, Estrada-Bellmann IE, Lees AJ.

Arch Med Res. 2018 Aug;49(6):418-420. doi: 10.1016/j.arcmed.2018.11.008. Epub 2018 Dec 19.

PMID:
30579627
13.

The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study.

Barbosa P, Djamshidian A, Lees AJ, Warner TT.

Mov Disord Clin Pract. 2018 Oct 4;5(5):519-522. doi: 10.1002/mdc3.12671. eCollection 2018 Sep-Oct.

PMID:
30515441
14.

Medical conferences: value for money?

Swash M, Lees AJ.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):483-484. doi: 10.1136/jnnp-2018-319248. Epub 2018 Oct 18. No abstract available.

PMID:
30337441
15.

Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate.

Magdalinou NK, Golden HL, Nicholas JM, Witoonpanich P, Mummery CJ, Morris HR, Djamshidian A, Warner TT, Warrington EK, Lees AJ, Warren JD.

Neurocase. 2018 Aug;24(4):204-212. doi: 10.1080/13554794.2018.1527368. Epub 2018 Oct 6.

16.

Crime and Parkinson's: The jury is out.

Santens P, De Letter M, Lees AJ, Krack P, van den Heuvel OA, Bloem BR.

Mov Disord. 2018 Jul;33(7):1092-1094. doi: 10.1002/mds.27436. No abstract available.

PMID:
30153392
17.

Small spiral, big mass.

Vijiaratnam N, Lees AJ, Morris HR.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1189-1190. doi: 10.1136/jnnp-2018-319019. Epub 2018 Aug 3. No abstract available.

PMID:
30076268
18.

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.

Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Müller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Höglinger GU, Holton JL, Ryten M, Morris HR.

Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.

19.

Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.

Ferreira JJ, Lees AJ, Poewe W, Rascol O, Rocha JF, Keller B, Soares-da-Silva P.

Neurology. 2018 May 22;90(21):e1849-e1857. doi: 10.1212/WNL.0000000000005557. Epub 2018 Apr 25.

PMID:
29695590
20.

"Flâneur neurologique in paris" - A guide to pinpointing the houses of famous neurologists in the late XIX century.

Teive HAG, Germiniani FMB, Camargo CHF, Walusinski O, Lees AJ.

J Clin Neurosci. 2018 Jun;52:32-36. doi: 10.1016/j.jocn.2018.04.001. Epub 2018 Apr 11. Review.

PMID:
29656001
21.

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT.

Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi: 10.1111/dmcn.13744. Epub 2018 Mar 30. Review.

22.

[Some reflections on the lasting importance of James Parkinson's Essay on the Shaking Palsy].

Lees AJ.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(1):75-76. doi: 10.17116/jnevro20181181175-76. Russian. No abstract available.

PMID:
29460909
23.

Endemic atypical parkinsonism.

Silveira-Moriyama L, Lees AJ.

J Neurol Sci. 2018 May 15;388:220-221. doi: 10.1016/j.jns.2018.02.018. Epub 2018 Feb 7. No abstract available.

PMID:
29449009
24.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
25.

Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test.

Morley JF, Cohen A, Silveira-Moriyama L, Lees AJ, Williams DR, Katzenschlager R, Hawkes C, Shtraks JP, Weintraub D, Doty RL, Duda JE.

NPJ Parkinsons Dis. 2018 Jan 15;4:2. doi: 10.1038/s41531-017-0039-8. eCollection 2018.

26.

Advice for those trying to find a cure for the shaking palsy.

Lees AJ.

Lancet Neurol. 2018 Jan;17(1):27-28. doi: 10.1016/S1474-4422(17)30430-1. Epub 2017 Dec 16. No abstract available.

PMID:
29263002
27.

Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.

Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1121-1123. doi: 10.1136/jnnp-2017-317298. Epub 2017 Nov 24. No abstract available.

PMID:
29175897
28.

From Sgt. Pepper to Dreamachines: My Scientific Odyssey With William S. Burroughs.

Lees AJ.

JAMA. 2017 Dec 12;318(22):2164-2166. doi: 10.1001/jama.2017.17914. No abstract available.

PMID:
29145555
29.

Reply: MRI findings of visual system alterations in Parkinson's disease.

Weil RS, McColgan P, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR.

Brain. 2017 Nov 1;140(11):e70. doi: 10.1093/brain/awx245. No abstract available.

30.

William Burroughs: Sailor of the Soul.

Lees AJ.

J Psychoactive Drugs. 2017 Nov-Dec;49(5):385-392. doi: 10.1080/02791072.2017.1357862. Epub 2017 Aug 10.

PMID:
28796595
31.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

32.

James Parkinson's Chimera: syndrome or disease?

Kempster PA, Hurwitz B, Lees AJ.

J R Coll Physicians Edinb. 2017 Jun;47(2):190-195. doi: 10.4997/JRCPE.2017.220.

PMID:
28675197
33.

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2017 Aug 1;74(8):970-976. doi: 10.1001/jamaneurol.2017.1125.

34.

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G; International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW.

PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.

35.

The relationship between the First World War and neurology: 100 years of "Shell Shock".

Pedroso JL, Linden SC, Barsottini OG, Maranhão P Filho, Lees AJ.

Arq Neuropsiquiatr. 2017 May;75(5):317-319. doi: 10.1590/0004-282X20170046.

36.

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.

Lees AJ, Ferreira J, Rascol O, Reichmann H, Stocchi F, Tolosa E, Poewe W.

Expert Rev Neurother. 2017 Jul;17(7):649-659. doi: 10.1080/14737175.2017.1336086. Epub 2017 Jun 5. Review.

PMID:
28580819
37.

Hemichoreo-hemibalism as a Manifestation of Central Nervous System Chronic Graft-versus-Host Disease.

Enriquez-Marulanda A, Sierra-Ruiz M, Jaramillo FJ, Escobar LA, Granados AM, Rodríguez-Rojas LX, Lees AJ, Orozco JL.

Mov Disord Clin Pract. 2017 May 25;4(4):495-498. doi: 10.1002/mdc3.12497. eCollection 2017 Jul-Aug. No abstract available.

38.

Concerns Regarding Opicapone as Adjunct to Levodopa Therapy-Reply.

Lees AJ, Rocha JF, Soares-da-Silva P.

JAMA Neurol. 2017 Jul 1;74(7):873. doi: 10.1001/jamaneurol.2017.0726. No abstract available.

PMID:
28531266
39.

Parkinson's disease - 200 years: the outstanding contribution of "Old Hubert".

Teive HA, Munhoz RP, Lees AJ.

Arq Neuropsiquiatr. 2017 Mar;75(3):192-194. doi: 10.1590/0004-282X20170006.

40.

Georges Simenon, Inspector Maigret and his relevance to the practice of Neurology.

Teive HA, Lees AJ.

Arq Neuropsiquiatr. 2017 Mar;75(3):189-191. doi: 10.1590/0004-282X20170019.

41.

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J.

Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31.

PMID:
28214264
42.

Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players.

Ling H, Morris HR, Neal JW, Lees AJ, Hardy J, Holton JL, Revesz T, Williams DD.

Acta Neuropathol. 2017 Mar;133(3):337-352. doi: 10.1007/s00401-017-1680-3. Epub 2017 Feb 15.

43.

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.

Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K; Swedish BioFINDER study.

Neurology. 2017 Mar 7;88(10):930-937. doi: 10.1212/WNL.0000000000003680. Epub 2017 Feb 8.

44.

Wilson's disease: the 60th anniversary of Walshe's article on treatment with penicillamine.

Teive HA, Barbosa ER, Lees AJ.

Arq Neuropsiquiatr. 2017 Jan;75(1):69-71. doi: 10.1590/0004-282X20160166.

45.

PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.

Noyce AJ, R'Bibo L, Peress L, Bestwick JP, Adams-Carr KL, Mencacci NE, Hawkes CH, Masters JM, Wood N, Hardy J, Giovannoni G, Lees AJ, Schrag A.

Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.

46.

9.4T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA.

Neuroimage Clin. 2017;13:154-163. doi: 10.1016/j.nicl.2016.11.015. Epub 2016 Nov 17.

47.

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

Lees AJ, Ferreira J, Rascol O, Poewe W, Rocha JF, McCrory M, Soares-da-Silva P; BIPARK-2 Study Investigators.

JAMA Neurol. 2017 Feb 1;74(2):197-206. doi: 10.1001/jamaneurol.2016.4703.

PMID:
28027332
48.

Subtle motor disturbances in PREDICT-PD participants.

Noyce AJ, Schrag A, Masters JM, Bestwick JP, Giovannoni G, Lees AJ.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):212-217. doi: 10.1136/jnnp-2016-314524. Epub 2016 Dec 16.

49.

9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA.

Neuroimage Clin. 2016 Nov 17;13:154-163. eCollection 2017.

50.

Foreword.

Lees AJ.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S1. doi: 10.1016/j.parkreldis.2016.11.002. Epub 2016 Nov 12. No abstract available.

PMID:
27863977

Supplemental Content

Support Center